NLARx Newsletter Header
NLARx News
June 22, 2010
In This Issue
Health Reform
News from the States
NLARx Summer Meeting
Other Conferences
Outrage of the Week
Pharmaceutical Pricing
Conflicts of Interest
Advertising & Marketing
Pharma Watch
PBM Watch
Patents & Generics
Medicare & Medicaid
Safety & Clinical Trials
NLARx on Facebook
Quick Links
Join Our Mailing List
NLARx News
State Gains in Transparency, Rx Legislation | >>more
News from the States
Connecticut: Connecticut Passes Law Insuring Access to VA Pricing for Veterans in Nursing Homes more
Massachusetts: 
Uphold the Ban on Pharmaceutical Marketing to Doctors: Advocates, Doctors, and Lawmakers call on the Legislature to Put Patients First more
Michigan:
Paying Too Much for Prescriptions? more
New York:
Manhattan Medicare Drug Costs Outpace Every Other Place in U.S. more
Vermont:
State Backs Down on Medicare Rebates more
NLARx Summer Meeting August 18th in Portland, Maine
Portland PierRegister now for our next meeting: We are meeting on the final day of the CSG Eastern Regional Conference (scheduled for August 15-18) in beautiful Portland Maine.  Learn the latest on what states are doing to lower drug costs and implement federal health reform including changes to Medicaid rebates and the Sunshine Act. Registration and meeting details: more
Other Upcoming Conferences
Prescription for Conflict: Should Industry Fund Continuing Medical Education? Presented by PharmedOut, June 25, Washington DC.  For more details and to register: more
Outrage of the Week - J&J Recall Continued
Johnson & Johnson Recalls Some More Medicines more
More Disputes Over Handling of Drug Recall more
Drug Maker Seen as Uncooperative on Inquiry more
Pharmaceutical Pricing
Glaxo To Novo: Pulling Out Of Greece Isn't Helpful more
AstraZeneca Pays $103M To Settle AWP Lawsuit more
Conflict of Interest, CME, and Academic Detailing
Academic Researchers Say Tour Yielded 23 Percent Increase In Patients Who Got Best, Cheapest Drugs more
Psychiatry Group Releases A New Code Of Conduct more
Advertising and Marketing
Johnson & Johnson Fights US Over Kickback Case more
How Much Does Pharma Spend on ePromtion? The Mystery Continues more
Drugmakers Continue 'Off-Label Marketing' Despite Large Fines more
Big Drug Companies Gave Out $3 Billion in Samples in '07 more
Pharma Watch
Pfizer Faces Trials in 200 Suits Over Hormone-Drugs more
AstraZeneca Gave FDA Faulty Data, Scientist Claims more
Meeting Held by Mylan Being Probed more
HHS Learns from SEC: Fraudster Execs will be Barred from Drug Industry more

PBM Watch
Walgreen and CVS Reach Deal on Filling Prescriptions more
Medco Benefits Amid CVS-Walgreen Spat more
Walgreen to Honor Existing CVS Caremark Terms more
A Dispute Over Filling Prescriptions more
Patents and Generics
No Refills: Where is the Future of Drug Discovery?more
Generic-Drug Delay Fight May Be Near `Turning Point,' FTC's Leibowitz Says more
Biased Agenda? A Law School, India & Drugmakers more
Medicare and Medicaid
With Medicaid Set to Expand, a Closer Look at Generic Policies more
Medicare Eye Study Finds Untapped Savings more
Safety and Clinical Trials
FDA Database Aims to Spark Orphan-Disease Drug Development more
FDA to Disclose More Safety Info on New Drugs more
A Radical View on Giving Statins more
Supreme Court To Review Adverse Event Disclosure more
FDA to Propose Tougher Rules for Outsourcing Drug Manufacturing more
NLARx on Facebook!
For up-to-the-minute posting of news of interest and events, become a fan of NLARx on Facebook here!